Some patients lose 30% of body weight
To increase affinity toward CD36, researchers modified the linker region of the VHL-based PROTAC MZ1 by introducing cleavable polar groups (e.g., carboxyl, amino, Boc-protected groups)
Get my baseline $99 Subscribe to our newsletter & join a community of 30,000+ Aussies Weight loss medications may assist in managing obesity when lifestyle changes alone have not led to sufficient results
What are semaglutide medications
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024)
Prior to initiation, train patients and their caregiver(s) on proper injection technique for the prescribed MOUNJARO presentation [see Instructions for Use]